Edgewise Therapeutics Inc (EWTX)
34.44
-0.04
(-0.10%)
USD |
NASDAQ |
Nov 05, 10:17
Edgewise Therapeutics Free Cash Flow: -104.72M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -104.72M |
| March 31, 2024 | -99.39M |
| December 31, 2023 | -97.69M |
| September 30, 2023 | -85.85M |
| June 30, 2023 | -76.63M |
| March 31, 2023 | -72.43M |
| December 31, 2022 | -58.18M |
| September 30, 2022 | -52.53M |
| Date | Value |
|---|---|
| June 30, 2022 | -47.95M |
| March 31, 2022 | -41.00M |
| December 31, 2021 | -34.18M |
| September 30, 2021 | -29.32M |
| June 30, 2021 | -23.88M |
| March 31, 2021 | -18.21M |
| December 31, 2020 | -14.84M |
Free Cash Flow Range, Past 5 Years
-104.72M
Minimum
Jun 2024
-14.84M
Maximum
Dec 2020
-57.12M
Average
-52.53M
Median
Sep 2022
Free Cash Flow Benchmarks
| Catalyst Pharmaceuticals Inc | 114.96M |
| Vertex Pharmaceuticals Inc | -1.426B |
| Sarepta Therapeutics Inc | -527.92M |
| Regenxbio Inc | -194.72M |
| Entrada Therapeutics Inc | -18.50M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -26.10M |
| Cash from Investing (Quarterly) | 37.37M |
| Cash from Financing (Quarterly) | 1.952M |
| Free Cash Flow Per Share (Quarterly) | -0.2815 |
| Free Cash Flow Yield | -3.93% |